US OptionsDetailed Quotes
NBIX250516P150000
- 26.84
- 0.000.00%
15min DelayClose Apr 24 16:00 ET
0.00High0.00Low
26.84Open26.84Pre Close0 Volume0 Open Interest150.00Strike Price0.00Turnover75.12%IV-16.45%PremiumMay 16, 2025Expiry Date44.24Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9766Delta0.0050Gamma2.39Leverage Ratio-0.0170Theta-0.0268Rho-2.33Eff Leverage0.0134Vega
Neurocrine Biosciences Stock Discussion
New Data: INGREZZA Outperforms Competitors with Perfect Therapeutic Dose Rate
Breakthrough: INGREZZA Achieves 59% Remission in Tardive Dyskinesia Patients Over 48 Weeks
Breakthrough: INGREZZA Phase 3 Data Reveals Powerful Chorea Control Across All Body Regions
Can Neurocrine's New VMAT2 Inhibitor Replicate Its Previous FDA Success? Phase 1 Trial Launches
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded down 0.95%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.99%, and the $Nasdaq Composite Index (.IXIC.US)$ fell 1.36%.
MACRO
Macroeconomic news might have swayed the market as jobs and unemployment data came in. The economy added 143,000 jobs in January, according to the BLS, which was low, but N...
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont oral solution
$BeiGene (BGNE.US)$ ⇨ Tisleli...
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinece...
Who led the selloff. Come on man 🚀🚀🚀
No comment yet